Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00590369 · ClinicalTrials.gov registry record · Phase 3
Negative Pressure Wound Therapy: Are All Systems Alike?
A Phase 3 study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- Phase 3
- Development phase
- 11
- Enrollment target
NCT00590369: Clinical Trial Phase 3 study, sponsored by The Cleveland Clinic.
NCT00590369 is a Phase 3 study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 11 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00590369, a Phase 3 study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 11 participants
- Enrollment target
Study Summary
Hypotheses: (1)Wound healing during hospital stay will be equal between systems, (2)RNs will perceive the Versatile One (EZCare) system as easier to use, (3)Costs related to dressing changes will be less with Versatile one (EZCare), (4)Hospital length of stay will be equal or shorter with the Versatile One (EzCare) system, (5) Nursing time using Versatile One (EZCare) will be less than or equal to VAC system, (6) Patients will report less pain during dressing changes with Versatile One (EZCare).
Primary Outcome
differences in wound healing rate at first dressing between devices; since 5 variables were assessed via a centimeter ruler
Interventions
- DEVICE KCI -VAC
- DEVICE Versatile One (EZCare)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2006-01 |
| Est. Completion | 2008-08 |
| Phase | Phase 3 |
Why NCT00590369 stopped before completion
NCT00590369 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which KCI -VAC is the first listed.
NCT00590369 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00590369 about?
NCT00590369 is a clinical study titled "Negative Pressure Wound Therapy: Are All Systems Alike?". Hypotheses: (1)Wound healing during hospital stay will be equal between systems, (2)RNs will perceive the Versatile One (EZCare) system as easier to use, (3)Costs related to dressing changes will be less with Versatile one (EZCare), (4)Hospital length of stay will be equal or shorter with the Versat...
What is the current status of trial NCT00590369?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 11 participants. The study started on 2006-01. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00590369?
The interventions under investigation include: KCI -VAC (DEVICE), Versatile One (EZCare) (DEVICE).
Who is sponsoring clinical trial NCT00590369?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00590369's enrollment target sits among peer trials
11 1989th of 2000 higher than 12 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia